Logo image of SGTX

SIGILON THERAPEUTICS INC (SGTX) Stock Analyst Ratings

NASDAQ:SGTX - Nasdaq - US82657L2060 - Common Stock - Currency: USD

22.47  -0.59 (-2.56%)

After market: 23 +0.53 (+2.36%)

Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to SGTX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 48.28. This target is 114.86% above the current price.
SGTX was analyzed by 9 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about SGTX.
In the previous month the buy percentage consensus was at a similar level.
SGTX was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

SGTX Historical Analyst RatingsSGTX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -31 -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 22.4721.2130.6048.2895.55 - -5.61% 36.18% 114.86% 325.23%

Related screens

SGTX Current Analyst RatingSGTX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2023-07-05 Canaccord Genuity Maintains Buy -> Buy
2023-07-03 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-06-30 BTIG Downgrade Buy -> Neutral
2023-06-30 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-05-26 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-05-25 Morgan Stanley Maintains Equal-Weight -> Equal-Weight
2023-01-18 Canaccord Genuity Initiate Buy
2021-12-23 Canaccord Genuity Maintains Buy
2021-12-01 Barclays Maintains Overweight
2021-11-30 Morgan Stanley Maintains Equal-Weight
2021-11-30 Jefferies Downgrade Buy -> Hold
2021-10-29 BTIG Initiate Buy
2021-07-19 Canaccord Genuity Maintains Buy
2021-07-16 Morgan Stanley Maintains Equal-Weight